Circadian Clock Regulation via Biomaterials for Nucleus Pulposus

© 2023 Wiley-VCH GmbH.

Détails bibliographiques
Publié dans:Advanced materials (Deerfield Beach, Fla.). - 1998. - 35(2023), 32 vom: 22. Aug., Seite e2301037
Auteur principal: Chen, Wei (Auteur)
Autres auteurs: Zheng, Dandan, Chen, Hao, Ye, Tingjun, Liu, Zhihong, Qi, Jin, Shen, Hongxing, Ruan, Huitong, Cui, Wenguo, Deng, Lianfu
Format: Article en ligne
Langue:English
Publié: 2023
Accès à la collection:Advanced materials (Deerfield Beach, Fla.)
Sujets:Journal Article circadian clock extracellular matrices intervertebral disc degeneration microfluidics tissue regeneration Biocompatible Materials Phosphatidylinositol 3-Kinases EC 2.7.1.-
Description
Résumé:© 2023 Wiley-VCH GmbH.
Circadian clock disorder during tissue degeneration has been considered the potential pathogenesis for various chronic diseases, such as intervertebral disc degeneration (IVDD). In this study, circadian clock-regulating biomaterials (ClockMPs) that can effectively activate the intrinsic circadian clock of nucleus pulposus cells (NPCs) in IVDD and improve the physiological function of NPCs for disc regeneration are fabricated via air-microfluidic technique and the chemical cross-linking between polyvinyl alcohol and modified-phenylboronic acid. In vitro experiments verified that ClockMPs can scavenge reactive oxygen species to maintain a stable microenvironment for the circadian clock by promoting the binding of BMAL1 and CLOCK proteins. ClockMPs can regulate the expression of core circadian clock genes by activating the PI3K-AKT pathway in NPCs to remodel the intrinsic circadian clock and promote extracellular matrix synthesis. Furthermore, in vivo experiments of IVDD treated with ClockMPs proved that ClockMPs can promote disc regeneration by regulating the circadian clock of NPCs. In conclusion, ClockMPs provided a novel and promising strategy for circadian clock regulation during tissue regeneration
Description:Date Completed 14.08.2023
Date Revised 20.10.2023
published: Print-Electronic
Citation Status MEDLINE
ISSN:1521-4095
DOI:10.1002/adma.202301037